EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland

Georgia Anita Weber iD, Sophie-Charlotte Bartel iD, Michael Boch iD, Christoph Rosen iD, Michael Bodmer, Balthasar Luzius Hug iD, Thomas Stammschulte iD, Patrick E Beeler iD

British Journal of Clinical Pharmacology · 2026-08 · 92 (8) · 2937-2948

DOI: 10.1002/bcp.70564 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 05.05.2026. Verfasst von Georgia Anita Weber und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty for Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Hospitalization, Drug-Related Side Effects and Adverse Reactions, International Classification of Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Reporting adverse drug reactions (ADRs) is essential for drug safety. In Switzerland, healthcare professionals are legally required to report serious and unlabelled ADRs, yet under‐reporting remains widespread. We tested a novel method to increase reporting of ADR‐related hospitalizations.

Methods

This retrospective observational study used ADR‐indicative ICD‐10 codes to screen admissions to four Swiss hospitals, identify suspected drugs and send individual case safety reports (ICSRs) of confirmed cases to Swissmedic.

Results

Participating hospitals previously reported ~18 ICSRs annually. During the study period (7/2023–12/2023), 200 ADR‐related hospitalizations were reported following a review of 814 pre‐filtered admissions. Most ICSR data were available in structured format: Median age of patients was 59 (interquartile range [IQR] 42–75); 87 (44%) males; median of two comorbidities (IQR 1–3); the three most frequent ADRs were ‘K52.1 Toxic gastroenteritis and colitis’ (11 [6%]), ‘T42.4 Poisoning by benzodiazepines’ (10 [5%]) and ‘R11 Nausea and vomiting’ (10 [5%]). Discharge reports contained free‐text information on suspected drugs: More than half of ADR‐related hospitalizations were caused by antineoplastics (45 [23%]), psycholeptics (38 [19%]), opioids and other analgesics (34 [17%]). The median time to screen a case was 1 min, 8 min to collect, compile and send data of confirmed cases.

Conclusion

The approach successfully increased reporting of serious ADRs. The time investment for creating ICSRs might soon be rendered obsolete, as most data are available in structured format, and large language models are key to identifying suspected drugs in discharge reports.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsHospitalizationDrug-Related Side Effects and Adverse ReactionsInternational Classification of DiseasesHumansSwitzerlandRetrospective StudiesMaleFemaleAgedMiddle AgedAdult

Stichwörter der Autor:innen

Switzerlandadverse drug reaction reporting systems, drug‐related side effects and adverse…hospitalization/statistics & numerical datapetrospective studiespharmacoepidemiology/statistics & numerical data, pharmacovigilance

Autor:innen und Institutionen

  • Faculty for Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.
  • Hospital Pharmacy, Lucerne Cantonal Hospital, Lucerne, Switzerland.
  • Hospital Pharmacy, Zug Cantonal Hospital, Baar, Switzerland.
  • Internal Medicine, Zug Cantonal Hospital, Baar, Switzerland.
  • Center for Clinical Research, Lucerne Cantonal Hospital/University of Lucerne, Lucerne, Switzerland.
  • Internal Medicine, Lucerne Cantonal Hospital, University Teaching and Research Hospital, Lucerne, Switzerland.

ORCID-Profile: Georgia Anita Weber, Sophie-Charlotte Bartel, Michael Boch, Christoph Rosen, Balthasar Luzius Hug, Thomas Stammschulte, Patrick E Beeler

Zitieren

APA

Weber, G. A., Bartel, S. C., Boch, M., Rosen, C., Bodmer, M., Hug, B. L., Stammschulte, T., & Beeler, P. E. (2026). Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland. British Journal of Clinical Pharmacology, 92(8), 2937-2948. https://doi.org/10.1002/bcp.70564

Vancouver

Weber GA, Bartel SC, Boch M, Rosen C, Bodmer M, Hug BL, et al. Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland. British Journal of Clinical Pharmacology. 2026;92(8):2937-2948. doi:10.1002/bcp.70564

BibTeX
@article{Weber2026,
  author = {Weber, Georgia Anita and Bartel, Sophie-Charlotte and Boch, Michael and Rosen, Christoph and Bodmer, Michael and Hug, Balthasar Luzius and Stammschulte, Thomas and Beeler, Patrick E},
  title = {Increasing the reporting of adverse drug reaction‐related hospitalizations using an ICD‐10‐based identification workflow: A multicentre study from Switzerland},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  volume = {92},
  number = {8},
  pages = {2937--2948},
  doi = {10.1002/bcp.70564}
}
Kostenlos starten →